Pediatric Genetic Testing - When and How to Test

Session Description
This webinar will focus on skills and concepts that help providers understand how and when to access genetic testing services, including targeted family history, types of genetic testing, and how to work with a genetics laboratory.

Session Learning Objectives:
At the conclusion of this session, participants should be able to:
a. Develop a targeted family history to assess genetic risks in children and adolescents 
b. Distinguish among different genetic tests and their clinical uses and factors to consider when selecting a laboratory for genetic testing 
Communicate to parents and patients the benefits and limitations, and potential harms of genetic testing
Planning Committee, Writers, and Editors
George Anadiotis, DO
Randall Children’s Hospital, Portland, OR
Nothing to disclose
Leah Burke, MD
UVM Medical Center
Nothing to disclose
June Carroll, MD
University of Toronto
Nothing to disclose
Vinayak Kottoor, MD
Mission Health, Asheville, NC
Nothing to disclose
John Mulvihill, MD
Children's Medical Research Institute, Oklahoma City, OK
Paid by NIH; Review panel- US Army NF grant program
Robert Saul, MD
Greenville Genetics Center
Nothing to disclose
Joan Scott, MS, CGC
Health Research Services Administration
Nothing to disclose
Tracy Trotter, MD
San Ramon Valley Primary Care, retired
Nothing to disclose
Mike Dougherty, PhD
American Society of Human Genetics
Nothing to disclose
Karen Hanson, MS, CGC
American Society of Human Genetics 
Nothing to disclose

CME Information 

Content Validation and Fair Balance

1. ASHG follows the ACCME policy on Content Validation for CME activities, which requires.
a) All recommendations involving clinical medicine must be based on evidence that is accepted within the profession of medicine as adequate justification for their indications and contraindications in the care of patients.
b) All scientific research referred to, reported or used in CME in support or justification of patient care recommendations must conform to the generally accepted standards of experimental design, data collection and analysis.
2.  Activities that fall outside the definition of CME/CE, i.e., “Educational activities that serve to maintain, develop, or increase the knowledge, skills, and professional performance and relationships that a physician uses to provide services for patients, the public, or the profession” (source: ACCME and AMA) will not be certified for credit. CME activities that promote recommendations, treatment, or manners of practicing medicine or pharmacy that are not within the definition of CME/CE, or are known to have risks or dangers that outweigh the benefits, or are known to be ineffective in the treatment of patients will not be certified for credit.
3.  Presentations and CME/CE activity materials must give a balanced view of therapeutic options; use of generic names will contribute to this impartiality. If the CME/CE educational materials or content includes trade names, where available, trade names from several companies must be used.
Accreditation Statement: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American College of Medical Genetics and Genomics and the American Society of Human Genetics. The American College of Genetics and Genomics is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation

The American College of Medical Genetics and Genomics designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Statement:
In accordance with the Accreditation Council for Continuing Medical Education (ACCME) and the policies of the American College of Medical Genetics and Genomics (ACMG) and the American Society of Human Genetics (ASHG), speakers and moderators presenting in sessions that offer CME and CEU credit must disclose, prior to the start of their presentations, the existence of any relevant financial interests and/or other relationship(s) they might have with the manufacturer(s) or provider(s) of any commercial product(s) or service(s), including diagnostic laboratories to be discussed during their presentation. All disclosures have been peer reviewed by the CME Subcommittee.